On May 6th, LabCentral will host "Navigating the Landscape of Drug Development," a panel event presented in collaboration with Just – Evotec Biologics. This session will explore the evolving landscape of biologics development through the lens of quality systems, regulatory strategy, and continuous manufacturing.
The conversation will feature Jeremiah Genest, Sr. Director of Quality; Kevin Ingham, Vice President of BioTherapeutics; and Petra Cavallero, Head of Regulatory Affairs at Just – Evotec Biologics. Together, they will share insights into how advanced manufacturing technologies are reshaping timelines, reducing costs, and enhancing scalability in drug development.
From ICH Q13 regulatory guidance to cutting-edge continuous processing technologies, the panel will highlight how Just – Evotec is designing agile, high-yield systems to increase global access to biologics — without compromising on quality.
Attendees can expect a deep dive into best practices for navigating regulatory pathways, implementing phase-appropriate quality systems, and embracing innovation in manufacturing.
Join Evotec CBO, Mattias Evers, and LabCentral CEO, Johannes Fruehauf, on Tuesday September 12th at 10 AM for a roundtable discussion with biotech leaders!
Featured topics will include current market conditions, pain points for growing biotechs, technology strategy, and more. If you’re a biotech founder or leader and would like to join this unique event, please be sure to register today as space is limited!
Featured Presenters
Featured Panelists
Jeremiah Genest
Sr. Director Quality
Petra Cavallero
Head of Regulatory Affairs
Kevin Ingham
VP, Site Head BioTherapeutics
Secure your spot today!
Secure your spot today - Space is limited!